NEW YORK (GenomeWeb) – Pacific Biosciences reported after the close of the market Wednesday that its first quarter 2014 revenues more than doubled year over year and grew 27 percent sequentially.

The Menlo Park, Calif.-based single-molecule sequencing technologies firm reported Q1 revenues of $11.6 million, compared to $5.6 million in Q1 2013 and up from $9.1 million in Q4 2013. It beat the consensus Wall Street estimate of $10.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.